0001209191-15-009472.txt : 20150204
0001209191-15-009472.hdr.sgml : 20150204
20150204165329
ACCESSION NUMBER: 0001209191-15-009472
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20150202
FILED AS OF DATE: 20150204
DATE AS OF CHANGE: 20150204
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: VERTEX PHARMACEUTICALS INC / MA
CENTRAL INDEX KEY: 0000875320
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 043039129
STATE OF INCORPORATION: MA
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 50 NORTHERN AVENUE
CITY: BOSTON
STATE: MA
ZIP: 02210
BUSINESS PHONE: 6173416393
MAIL ADDRESS:
STREET 1: 50 NORTHERN AVENUE
CITY: BOSTON
STATE: MA
ZIP: 02210
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Silva Paul M
CENTRAL INDEX KEY: 0001446372
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-19319
FILM NUMBER: 15576184
MAIL ADDRESS:
STREET 1: C/O VERTEX PHARMACEUTICALS INCORPORATED
STREET 2: 130 WAVERLY ST
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2015-02-02
0
0000875320
VERTEX PHARMACEUTICALS INC / MA
VRTX
0001446372
Silva Paul M
C/O VERTEX PHARMACEUTICALS INCORPORATED
50 NORTHERN AVENUE
BOSTON
MA
02210
0
1
0
0
SVP & Corp Controller
Common Stock
2015-02-02
4
M
0
1125
37.86
A
18312
D
Common Stock
2015-02-02
4
S
0
300
108.11
D
18012
D
Common Stock
2015-02-02
4
S
0
668
109.89
D
17344
D
Common Stock
2015-02-02
4
S
0
157
110.76
D
17187
D
Common Stock
2015-02-03
4
M
0
938
38.80
A
18125
D
Common Stock
2015-02-03
4
S
0
438
107.04
D
17687
D
Common Stock
2015-02-03
4
S
0
300
108.16
D
17387
D
Common Stock
2015-02-03
4
S
0
100
109.50
D
17287
D
Common Stock
2015-02-03
4
S
0
100
111.32
D
17187
D
Common Stock
169
I
401(k)
Stock Option (right to buy)
37.86
2015-02-02
4
M
0
1125
0.00
D
2022-02-01
Common Stock
1125
4500
D
Stock Option (right to buy)
38.80
2015-02-03
4
M
0
938
0.00
D
2021-02-02
Common Stock
938
0
D
Transaction made pursuant to Mr. Silva's company approved trading plan under Rule 10b5-1.
Open market sales reported on this line occurred at a weighted average price of $108.11 (range $107.94 to $108.22).
Mr. Silva undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.
Open market sales reported on this line occurred at a weighted average price of $109.89 (range $109.51 to $110.42).
Open market sales reported on this line occurred at a weighted average price of $110.76 (range $110.74 to $110.80).
Open market sales reported on this line occurred at a weighted average price of $107.04 (range $106.77 to $107.45).
Open market sales reported on this line occurred at a weighted average price of $108.16 (range $108.03 to $108.40).
The option vests in 16 quarterly installments from 02/02/2012.
Fully vested.
Omar White, Attorney-In-Fact
2015-02-04